Neumayer Hh

1.6k total citations
38 papers, 468 citations indexed

About

Neumayer Hh is a scholar working on Surgery, Transplantation and Nephrology. According to data from OpenAlex, Neumayer Hh has authored 38 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Transplantation and 6 papers in Nephrology. Recurrent topics in Neumayer Hh's work include Renal Transplantation Outcomes and Treatments (12 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Neumayer Hh is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Neumayer Hh collaborates with scholars based in Germany, Switzerland and Austria. Neumayer Hh's co-authors include Karl Wagner, J.L. Rodicio, G Thiel, M. Wiesel, A Tarantino, Yves Vanrenterghem, Eleanor L. Ramos, Willem van Son, Josep M. Grinyó and Soulillou Jp and has published in prestigious journals such as Journal of the American Society of Nephrology, Transplantation and Journal of Medical Internet Research.

In The Last Decade

Neumayer Hh

37 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neumayer Hh Germany 12 218 135 79 70 64 38 468
Timothy J. Schroeder United States 12 253 1.2× 143 1.1× 50 0.6× 82 1.2× 35 0.5× 19 388
David H. Van Buren United States 10 251 1.2× 191 1.4× 82 1.0× 85 1.2× 22 0.3× 19 439
Eduard M. Scholten Netherlands 7 393 1.8× 154 1.1× 114 1.4× 153 2.2× 60 0.9× 9 473
T J Schroeder United States 11 227 1.0× 126 0.9× 32 0.4× 71 1.0× 26 0.4× 45 354
Agnes Lo United States 17 405 1.9× 336 2.5× 65 0.8× 89 1.3× 33 0.5× 25 662
R. Panek Canada 8 371 1.7× 159 1.2× 78 1.0× 180 2.6× 30 0.5× 10 457
Van Buren Ct United States 10 168 0.8× 120 0.9× 27 0.3× 62 0.9× 25 0.4× 34 343
P.F. Westeel France 12 456 2.1× 132 1.0× 161 2.0× 107 1.5× 143 2.2× 25 689
Jean-Christophe Szelag France 9 432 2.0× 88 0.7× 143 1.8× 140 2.0× 104 1.6× 15 652
Anne Maisin France 15 268 1.2× 81 0.6× 49 0.6× 147 2.1× 184 2.9× 39 601

Countries citing papers authored by Neumayer Hh

Since Specialization
Citations

This map shows the geographic impact of Neumayer Hh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neumayer Hh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neumayer Hh more than expected).

Fields of papers citing papers by Neumayer Hh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neumayer Hh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neumayer Hh. The network helps show where Neumayer Hh may publish in the future.

Co-authorship network of co-authors of Neumayer Hh

This figure shows the co-authorship network connecting the top 25 collaborators of Neumayer Hh. A scholar is included among the top collaborators of Neumayer Hh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neumayer Hh. Neumayer Hh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Khadzhynov, Dmytro, Torsten Slowinski, Ina Lieker, et al.. (2011). Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD. International Journal of Clinical Pharmacology and Therapeutics. 49(11). 656–665. 21 indexed citations
3.
Kleeberg, Lorenz, Stanislao Morgera, Christian Jakob, et al.. (2009). Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy. European journal of medical research. 14(2). 47–47. 11 indexed citations
4.
Schneider, Miklós, Lutz Liefeldt, Detlef Kindgen‐Milles, et al.. (2007). Efficacy and safety of intermittent hemodialysis using citrate as anticoagulant: a prospective study. Clinical Nephrology. 68(11). 302–307. 12 indexed citations
5.
Behrend, Matthias, Josep M. Grinyó, Yves Vanrenterghem, et al.. (1999). Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation. 68(3). 391–396. 173 indexed citations
6.
Brunkhorst, R., Neumayer Hh, Klemens Budde, et al.. (1999). HUMAN SAFETY AND PHARMACOLOGY OF FTY 720. Transplantation. 67(7). S153–S153. 11 indexed citations
7.
Hh, Neumayer, R. Brunkhorst, Klemens Budde, et al.. (1999). HUMAN PHARMACOKINETICS OF FTY 720. Transplantation. 67(7). S204–S204. 10 indexed citations
8.
Pichlmayr, R., Yves Vanrenterghem, JP Squifflet, et al.. (1996). Randomised trial comparing Tacrolimus and cyclosporin in the prevention of renal allograft rejection. European study. Journal of the American Society of Nephrology. 7(9). 1917. 3 indexed citations
9.
Hh, Neumayer, Klemens Budde, L. Färber, et al.. (1996). Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.. PubMed. 45(5). 326–31. 6 indexed citations
10.
John, Stefan, Neumayer Hh, & Michael H. Weber. (1994). Serum circulating ICAM-1 levels are not useful to indicate active vasculitis or early renal allograft rejection.. PubMed. 42(6). 369–75. 9 indexed citations
11.
Behr, Th., William H. Becker, E Günter, et al.. (1994). Perfusion scintigraphy and color-coded duplex sonography in a minimally perfused renal allograft.. PubMed. 61(1). 28–31. 1 indexed citations
12.
Hh, Neumayer, L. Färber, Paul M. Haller, et al.. (1994). Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month.. PubMed. 26(5). 2944–8. 11 indexed citations
13.
Hh, Neumayer, et al.. (1992). [Decreased blood pressure in sleep and left ventricular hypertrophy in patients with kidney transplants].. PubMed. 81 Suppl 2. 17–9. 3 indexed citations
14.
Fritschka, Emanuel, et al.. (1991). [Effect of erythropoietin therapy on alpha receptor density in chronic dialysis patients].. PubMed. 86(7). 353–9. 1 indexed citations
15.
Hh, Neumayer, et al.. (1990). Metabolism of central neurotransmitters during development of tolerance to the anticonvulsant effect of clonazepam and of physical dependence on the drug in dogs.. PubMed. 305. 172–82. 3 indexed citations
16.
Hh, Neumayer, et al.. (1988). Cyclosporine immunosuppression and early kidney graft function.. PubMed. 20(3 Suppl 3). 226–32. 1 indexed citations
17.
Wagner, Karl & Neumayer Hh. (1987). Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6-month follow-up.. PubMed. 19(1 Pt 2). 1353–7. 26 indexed citations
18.
Hh, Neumayer, et al.. (1985). Beneficial effects of long-term prostaglandin E2 infusion on the course of postischemic acute renal failure. Long-term studies in chronically instrumented conscious dogs.. PubMed. 8(3). 159–68. 6 indexed citations
19.
Schultze, G., et al.. (1984). The impact of eicosanoids on compliance, cardiovascular performance, and coagulation during hemodialysis.. PubMed. 43(8-9). S426–9. 2 indexed citations
20.
Wagner, Karl, et al.. (1983). Influence of prostaglandin A1 on renal filtration, hemodynamics and excretion. Investigations in chronically instrumented conscious dogs on a low- and high-sodium diet.. PubMed. 6(4). 186–96. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026